healthy volunteers no medical condition
Conditions
Interventions
Trade Name: Victoza
Pharmaceutical Form: Solution for injection
INN or Proposed INN: LIRAGLUTIDE
CAS Number: 204656-20-2
Current Sponsor code: Liraglutide
Other descriptive name: Liraglutide
Concentra
Sponsors
KULeuven
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Healthy volunteers (18-45 years) who have no bowel symptoms and who are in good general health are eligible for the study. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: • They have relevant underlying disease (cardia, pulmonary, metabolic, kidney or liver disease, …) • They have a history of esophageal or gastric surgery, or recurrent or intermittent upper gastrointestinal symptoms (upper abdominal pain, nausea, vomiting, bothersome fullness or early satiation, heartburn, regurgitation,…) • They have a history of allergy to several types of drugs or food. • They have ever been treated for depression • There is a possibility of becoming pregnant during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: We set out to investigate the effect of liraglutide on the relation between gastric accommodation and satiation by measuring the IGP during intragastric nutrient drink infusion.;Secondary Objective: /;Primary end point(s): liquid nutrient tolerance to reach maximum satiation | — |
Countries
Belgium
Outcome results
None listed